Suppr超能文献

朊病毒病潜伏期的理论建模

Theoretical modeling of prion disease incubation.

作者信息

Kulkarni R V, Slepoy A, Singh R R P, Cox D L, Pázmándi F

机构信息

Department of Physics, University of California, Davis, California, USA.

出版信息

Biophys J. 2003 Aug;85(2):707-18. doi: 10.1016/S0006-3495(03)74514-7.

Abstract

We apply a theoretical aggregation model to laboratory and epidemiological prion disease incubation time data. In our model, slow growth of misfolded protein aggregates from small initial seeds controls the latent or lag phase; aggregate fissioning and subsequent spreading leads to an exponential growth phase. Our model accounts for the striking reproducibility of incubation times for high dose inoculation of lab animals. In particular, low dose yields broad incubation time distributions, and increasing dose narrows distributions and yields sharply defined onset times. We also explore how incubation time statistics depend upon aggregate morphology. We apply our model to fit the experimental dose-incubation curves for distinct strains of scrapie, and explain logarithmic variation at high dose and deviations from logarithmic behavior at low dose. We use this to make testable predictions for infectivity time-course experiments.

摘要

我们将一个理论聚集模型应用于实验室和流行病学朊病毒疾病潜伏期数据。在我们的模型中,从小的初始种子开始的错误折叠蛋白聚集体的缓慢生长控制着潜伏期或延迟期;聚集体裂变及随后的扩散导致指数增长期。我们的模型解释了高剂量接种实验动物时潜伏期惊人的可重复性。特别是,低剂量会产生较宽的潜伏期分布,而增加剂量会使分布变窄并产生明确界定的发病时间。我们还探讨了潜伏期统计数据如何依赖于聚集体形态。我们应用我们的模型来拟合不同毒株羊瘙痒病的实验剂量-潜伏期曲线,并解释高剂量下的对数变化以及低剂量下与对数行为的偏差。我们以此对感染性时间进程实验做出可检验的预测。

相似文献

1
Theoretical modeling of prion disease incubation.
Biophys J. 2003 Aug;85(2):707-18. doi: 10.1016/S0006-3495(03)74514-7.
2
A general model of prion strains and their pathogenicity.
Science. 2007 Nov 9;318(5852):930-6. doi: 10.1126/science.1138718.
3
Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Biochem Biophys Res Commun. 2005 Jan 14;326(2):339-43. doi: 10.1016/j.bbrc.2004.11.039.
4
Statistical mechanics of prion diseases.
Phys Rev Lett. 2001 Jul 30;87(5):058101. doi: 10.1103/PhysRevLett.87.058101. Epub 2001 Jul 12.
5
Generation of genuine prion infectivity by serial PMCA.
Vet Microbiol. 2007 Aug 31;123(4):346-57. doi: 10.1016/j.vetmic.2007.04.004. Epub 2007 Apr 7.
7
Prion protein interconversions and the transmissible spongiform encephalopathies.
Structure. 1999 Oct 15;7(10):R231-40. doi: 10.1016/s0969-2126(00)80049-0.
8
Insights into prion strains and neurotoxicity.
Nat Rev Mol Cell Biol. 2007 Jul;8(7):552-61. doi: 10.1038/nrm2204.
9
Spongiform encephalopathies. Tracking turncoat prion proteins.
Nature. 1997 Jul 17;388(6639):228-9. doi: 10.1038/40752.

引用本文的文献

1
Scaling analysis reveals the mechanism and rates of prion replication in vivo.
Nat Struct Mol Biol. 2021 Apr;28(4):365-372. doi: 10.1038/s41594-021-00565-x. Epub 2021 Mar 25.
2
Emergence of prions selectively resistant to combination drug therapy.
PLoS Pathog. 2020 May 18;16(5):e1008581. doi: 10.1371/journal.ppat.1008581. eCollection 2020 May.
3
Correlation analysis for the incubation period of prion disease.
Prion. 2012 Jul 1;6(3):276-81. doi: 10.4161/pri.19638.
4
Contact-induced structure transformation in transmembrane prion propagation.
Biophys J. 2007 Apr 15;92(8):2704-10. doi: 10.1529/biophysj.106.098335. Epub 2007 Jan 26.
5
Prion disease: exponential growth requires membrane binding.
Biophys J. 2006 Jun 1;90(11):L77-9. doi: 10.1529/biophysj.106.081703. Epub 2006 Mar 31.
6
Simulations of oligomeric intermediates in prion diseases.
Biophys J. 2003 Oct;85(4):2213-23. doi: 10.1016/S0006-3495(03)74647-5.

本文引用的文献

1
Oxidative damage to nucleic acids in human prion disease.
Neurobiol Dis. 2002 Apr;9(3):275-81. doi: 10.1006/nbdi.2002.0477.
2
Structural studies of the scrapie prion protein by electron crystallography.
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3563-8. doi: 10.1073/pnas.052703499. Epub 2002 Mar 12.
3
Prion diseases: dynamics of the infection and properties of the bistable transition.
Biophys J. 2001 Nov;81(5):2517-29. doi: 10.1016/S0006-3495(01)75897-3.
4
Statistical mechanics of prion diseases.
Phys Rev Lett. 2001 Jul 30;87(5):058101. doi: 10.1103/PhysRevLett.87.058101. Epub 2001 Jul 12.
5
Lipid rafts and signal transduction.
Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. doi: 10.1038/35036052.
6
Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro.
Arch Virol Suppl. 2000(16):265-73. doi: 10.1007/978-3-7091-6308-5_25.
7
Scrapie infections initiated at varying doses: an analysis of 117 titration experiments.
Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1043-50. doi: 10.1098/rstb.2000.0641.
8
Designing drugs to stop the formation of prion aggregates and other amyloids.
Biophys Chem. 2000 Dec 15;88(1-3):47-59. doi: 10.1016/s0301-4622(00)00197-6.
9
Mapping the parameters of prion-induced neuropathology.
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10573-7. doi: 10.1073/pnas.180317097.
10
Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5836-41. doi: 10.1073/pnas.110523897.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验